ESR1 and breast cancer: In experimental models of ER+ breast cancer cell lines, prolonged endocrine deprivation led to the emergence of acquired resistance driven by increased PI3K signaling, with a proteomic analysis revealing enhanced phosphorylation of mTOR and Akt [25].